Top Pharma Trends of 2024 & 2025
Here are the current pharma trends of 2024 & 2025, found using our software tool and selected based on their growth and global popularity across sites like Google, TikTok, Reddit, Twitter, YouTube, Amazon, and more. These are not fads, such as new movies or social media challenges – rather they’re long-term global pharma trends that are likely to see continued growth throughout 2024 & 2025. We’ve also included our analysis on these new emerging trends below.
Mounjaro
Mounjaro is an injectable drug for the treatment of Type 2 diabetes. With the generic name tirzepatid, Mounjaro works by decreasing food intake, delaying gastric emptying, increasing insulin activity, reducing glucagon levels, and enhances insulin secretion. … Read more
Natera
Natera is a company that specializes in genetic testing. The company offers a variety of tests, including tests for prenatal genetic disorders, cancer, and ancestry. Natera is one of the leading providers of genetic testing in the world. … Read more
Ozempic
Ozempic is a once-weekly injection for the treatment of type 2 diabetes. The medication is a glucagon-like peptide-1 receptor agonist, which helps the body to produce more insulin and lowers blood sugar levels. … Read more
Skyrizi
Skyrizi is a drug that is used to treat psoriasis. It is a biologic medication that is administered through an injection. It is a new drug that was approved by the FDA in 2019. … Read more
Rinvoq
Rinvoq is a prescription drug for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ulcerative colitis (UC), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). The drug works by blocking certain signals inside the body's cells that are thought to cause inflammation. … Read more
Non Stimulant ADHD
Non stimulant ADHD treatments are treatments for ADHD that do not contain stimulants. These treatments can include behavioral therapy, medications, and dietary changes. Non stimulant ADHD medications include Strattera, Kapvay, and Intuniv. … Read more
Dupixent
Dupixent is a prescription medication or biologic that is used to treat moderate to severe atopic dermatitis, a type of eczema. It is a monoclonal antibody that is designed to inhibit the activity of interleukin-4 and interleukin-13, which are proteins that are involved in the inflammation process. … Read more
NIPT
NIPT is a non-invasive prenatal test that screens for chromosomal abnormalities and other genetic conditions in the fetus. The test is performed by taking a blood sample from the mother and analyzing the DNA of the fetus. … Read more
Rybelsus
Rybelsus is a prescription medication for type 2 diabetes and may also cause weight loss. The medication's active ingredient is semaglutide which lowers blood sugar by increasing the body's release of insulin in the pancreas. … Read more
Farxiga
Farxiga is a drug that is used to treat type 2 diabetes. The drug belongs to a class of medications called SGLT2 inhibitors, which work by preventing the body from reabsorbing glucose. This lowers blood sugar levels in people with diabetes. … Read more
Jardiance
Jardiance is a prescription medication for the treatment of type 2 diabetes. The medication works by blocking the activity of SGLT2, a protein that removes sugar from the blood. … Read more
Remote Patient Monitoring
Remote patient monitoring is the process of remotely tracking a patient's health status and symptoms. This can be done through various methods such as phone apps, wearable sensors, or home health monitors. … Read more
Kesimpta
Kesimpta is a prescription medication for the treatment of relapsing multiple sclerosis. The drug comes in the form of an injectable. … Read more
Tagrisso
Tagrisso is a drug that is used to treat non-small cell lung cancer. It is a pill that is taken once a day and works by blocking the activity of a protein that helps the cancer cells grow. … Read more
Liver Injection
A liver injection is made from liver extract or other combination medicine. The injection may be used to treat a variety of conditions, including cancer, hepatitis, and cirrhosis. … Read more
Softgel Capsule
A softgel capsule is a gelatin capsule that is designed to be soft and easily swallowed. The capsules are often used to encapsulate liquids or powders and can be found in both prescription and over-the-counter medications. … Read more
Trend Highlight – GoodRx
Consumers are often more comfortable paying inconsistent rates when a good or service is one-off – like surgery – and less comfortable paying inconsistent rates when a good is undifferentiated – like prescription drugs, where a price increase doesn't necessarily suggest better product quality.
In spite of this, prescription drugs can have wildly different prices even among stores that are only miles apart. By searching for a specific drug, GoodRx shows users a map of nearby pharmacies with overlaid drug prices.
One of the strongest drivers of growth for GoodRx is doctor recommendations. In fact, GoodRx says that around 1/3 of U.S. doctors provide information about the company to their patients. With access to lower prices, patients can more often afford the medication and are more likely to stick to the treatment course. This means superior results, leading to happier patients and better business for doctors.
Today, more than 10 million Americans use GoodRx every month to lower their healthcare costs.
Trend Highlight – How Bluechew Is Disrupting The Erectile Dysfunction Drugs Market
Bluechew - a chewable tablet for erectile dysfunction - is different from competitor products marketed by Hims and Roman in one big way: The official site only processes ~¼ of the orders; the rest are processed on a series of affiliate sites that are all tied back to a single move the brand made that seems to have defined the company's high growth trajectory: posting their site on CrakRevenue.com, a marketplace for affiliate programs
Lookalikes of the official site (bluechew.com) can be found at bluechews.com, chew.blue (25M visits in March 2020), and more. The affiliate sites' footers all include links back to CrakRevenue, where the approach has been so successful that CrakRevenue did a case study on BlueChew in which they called it their most profitable program over the past 5 years. In fact, they listed the payout per sale at $50.
Because CrakRevenue has every incentive to help their affiliates perform, the company posts guidelines and provides prebuilt marketing funnel templates. One of the biggest guideline sets is around the framing of the product. For years, Cialis and Viagra were clearly labeled as drugs to solve issues had by "older men". CrakRevenue argues that this caps the market and holds it back from ever becoming a trend among younger men.
BlueChew claims the chewable factor -decreases the time it takes for the drug to start working. And though the difference in speed between chewable forms of the drug and capsule forms is debated in papers, the company has brought this feature to the front and center of its marketing.
Trend Highlight – Restaurant-Menu Medicine
Searches for Adderall have a unique seasonality in Google Trends whose pattern mimics that of education software and reflects one driver of changes in Adderall demand: school exams. Demand for Adderall and similar drugs has been rising for decades, with much of the rise coming from higher rates of diagnosis. In the last two decades, the number of children with ADHD diagnoses doubled.
Done ADHD ties in to both higher demand and higher awareness by giving people a way to get an ADHD diagnosis online, and then get a prescription.
The model of using a test to sell a product extends well beyond ADHD medication: it’s used in everything from online hearing tests and sleep studies to online internet speed tests and GPU stress tests for selling computer components.
More broadly, the entire approach to getting medical treatment is inverting. The pre-Internet approach was that a person went to a doctor, who would recommend a specialist, who would write a prescription. Today, it's easier to do research independently, online, especially on problems where the symptoms are self-reported. So an increasingly common cycle is to go online, find a specialist and get a prescription. It’s “restaurant-menu medicine”, where consumers choose exactly what they know they want. Instead of being the main player in the treatment process, doctors are relegated to being gatekeepers who double-check a self-diagnosis and provide a prescription.
Trend Highlight – The Changing Dynamics of Clinical Studies
Today, Craigslist is still cited by many universities as the best place to recruit participants for clinal trials.
It’s all part of the great lengths pharma companies go to in order to get their new drugs approved. The total bill for developing a new drug averages around $2.6 billion and part of this is clinical trials. Beyond their direct cost, there’s a huge time cost too. Most clinical trials get dragged out which can cost pharma companies even more in lost revenue.
Even still, clinical trials are very inefficient: 70% of clinical trial participants live more than 2 hours from trial sites.
As telemedicine startups push medicine and testing kits into consumers' homes for treatment, pharma companies are increasingly doing the same for drug research.
By helping to coordinate decentralized trials, Medable is able to reduce clinical trial times by 50%, equating to enormous savings.
Some companies find strategic ways to bypass regulations altogether: Plenity is one of the fastest-growing weight loss aids and even though it looks like a pill, the company behind it was able to get it classified as a medical device rather than a drug.
The FDA approval process for medical devices allows approval in cases where a device shows equivalent functionality to an existing treatment, which is a much cheaper and faster approach than the oftentimes billion-dollar investment of a full clinical trial.
See all 4,751 Pharmatrends
See all 4,751 Pharmatrends